Dipak Panigrahi
Plus aucun poste en cours
Profil
Dipak Panigrahi served as the Chief Medical Officer and SVP-Research & Development at QLT, Inc. from 2010 to 2011.
He also worked as the Vice President-Medical Affairs at Sucampo Pharmaceuticals, Inc. Dr. Panigrahi received his undergraduate degree from The Johns Hopkins University and his graduate and doctorate degrees from Hahnemann University.
Anciens postes connus de Dipak Panigrahi
Sociétés | Poste | Fin |
---|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Directeur Technique/Scientifique/R&D | 22/02/2011 |
SUCAMPO PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Dipak Panigrahi
Hahnemann University | Doctorate Degree |
The Johns Hopkins University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Sucampo Pharmaceuticals, Inc.
Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD. | Health Technology |